![SouthEast - News Channel Nebraska](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/011/175/normal/Screenshot_2024-01-03_111519.png?1704280553)
Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China
SouthEast - News Channel Nebraska,
Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics…